Thorium-232

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

WikiDoc Resources for Thorium-232

Articles

Most recent articles on Thorium-232

Most cited articles on Thorium-232

Review articles on Thorium-232

Articles on Thorium-232 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Thorium-232

Images of Thorium-232

Photos of Thorium-232

Podcasts & MP3s on Thorium-232

Videos on Thorium-232

Evidence Based Medicine

Cochrane Collaboration on Thorium-232

Bandolier on Thorium-232

TRIP on Thorium-232

Clinical Trials

Ongoing Trials on Thorium-232 at Clinical Trials.gov

Trial results on Thorium-232

Clinical Trials on Thorium-232 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Thorium-232

NICE Guidance on Thorium-232

NHS PRODIGY Guidance

FDA on Thorium-232

CDC on Thorium-232

Books

Books on Thorium-232

News

Thorium-232 in the news

Be alerted to news on Thorium-232

News trends on Thorium-232

Commentary

Blogs on Thorium-232

Definitions

Definitions of Thorium-232

Patient Resources / Community

Patient resources on Thorium-232

Discussion groups on Thorium-232

Patient Handouts on Thorium-232

Directions to Hospitals Treating Thorium-232

Risk calculators and risk factors for Thorium-232

Healthcare Provider Resources

Symptoms of Thorium-232

Causes & Risk Factors for Thorium-232

Diagnostic studies for Thorium-232

Treatment of Thorium-232

Continuing Medical Education (CME)

CME Programs on Thorium-232

International

Thorium-232 en Espanol

Thorium-232 en Francais

Business

Thorium-232 in the Marketplace

Patents on Thorium-232

Experimental / Informatics

List of terms related to Thorium-232


Overview

Thorium-232 is the primary abundant nuclide of thorium. It is a slightly unstable radionuclide that is found in the earth's crust. It is a fertile material able to absorb a neutron and undergo transmutation into a nuclide that is able to support fission (uranium-233).

In the form of Thorotrast, a thorium oxide suspension, it was used as contrast medium in early X-ray diagnostics. Thorium-232 is now classified as carcinogenic. The half-life of thorium-232 is 1.405Template:E years. Template:WH Template:WikiDoc Sources